Site Initiation Visit (SIV)

Site Initiation Visit (SIV) - Axcellant

Site Initiation Visit (SIV)

  1. lut 28, 2025

What Does the 'Site Initiation Visit (SIV)’ Mean?

A Site Initiation Visit (SIV) is a crucial meeting that takes place before a clinical trial begins at a specific research site. It is conducted by the sponsor or Contract Research Organization (CRO) to ensure that the site’s staff is prepared to carry out the study according to the protocol and regulatory requirements.

During an SIV, the study team reviews important aspects of the trial, including the protocol, investigational product handling, data collection procedures, and safety reporting. The visit also serves as an opportunity to address any questions or concerns from the site staff and to confirm that all necessary resources and equipment are in place for the study to commence.

Why Is the 'Site Initiation Visit (SIV)’ Important in Clinical Research?

The Site Initiation Visit (SIV) is crucial in clinical research as it ensures that all participating sites are adequately prepared to conduct the study in compliance with the protocol and regulatory standards. This standardization across sites helps maintain data integrity and patient safety, which are fundamental to the success and validity of clinical trials.

SIVs also serve as a critical communication point between sponsors, CROs, and site staff, fostering a shared understanding of study objectives and procedures. By addressing potential issues and clarifying expectations before the trial begins, SIVs can significantly reduce protocol deviations and improve overall study efficiency and quality.

Good Practices and Procedures

  1. Conduct a pre-SIV assessment to tailor the visit agenda to the site’s specific needs and experience level
  2. Utilize interactive training methods, such as role-playing exercises, to reinforce key protocol procedures
  3. Implement a post-SIV quiz to verify comprehension and identify areas requiring additional clarification
  4. Establish a mentorship program pairing experienced staff with new team members to support ongoing training
  5. Schedule a follow-up remote session within 2-4 weeks to address any questions that arise after the initial SIV

Related Terms

Resources

How ACT EU Is Forcing a Global Approach to Trial Timelines

Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…

Axcellant at ICNC Berlin: Following the Future of Nuclear Cardiology – and helping bring it to clinical reality

The Axcellant team recently attended the International Conference on Nuclear Cardiology (ICNC) in Berlin – one of the most important…

Axcellant Establishes Advisory Board to Strengthen Clinical and Strategic Leadership

Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…